These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32314427)

  • 1. The differential diagnosis of basophilia in patients undergoing BCR-ABL testing.
    Smith CJ; Kluck LA; Ruan GJ; Ashrani AA; Hook CC; Marshall AL; Pruthi RK; Shah MV; Wolanskyj-Spinner A; Gangat N; Go RS
    Am J Hematol; 2020 Sep; 95(9):E216-E217. PubMed ID: 32314427
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia.
    Min CK; Yang IH; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Acta Haematol; 2000; 104(2-3):135-8. PubMed ID: 11154991
    [No Abstract]   [Full Text] [Related]  

  • 3. BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests.
    Ogunleye F; Ibrahim M; Allen E; Brennan N; Huang J; Yu Z; Huben M; Jaiyesimi I
    J Oncol Pract; 2016 Dec; 12(12):e1001-e1005. PubMed ID: 27624943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization for BCR-ABL.
    Drummond MW; Allan EK; Pearce A; Holyoake TL
    Methods Mol Med; 2004; 97():103-16. PubMed ID: 15064488
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
    Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PCR testing in chronic myeloid leukemia.
    Jabbour EJ
    Clin Adv Hematol Oncol; 2015 Dec; 13(12):808-10. PubMed ID: 27058845
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program.
    Matsushita H; Yamamoto M; Tsuboi K; Masukawa A; Arakawa S; Asai S; Ogawa Y; Ando K; Miyachi H
    Clin Chem Lab Med; 2009; 47(7):885-7. PubMed ID: 19575551
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
    Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
    Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
    Yujie W; Yu Z; Sixuan Q; Li W; Peng L; Zeng G; Sujiang Z; Jianyong L
    Leuk Lymphoma; 2012 Mar; 53(3):451-5. PubMed ID: 21933042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
    Langabeer SE; Bhreathnach Ú; Cahill MR; Elhassadi E; Ní Loingsigh S; Conneally E; Enright H
    Blood Cells Mol Dis; 2021 Mar; 87():102521. PubMed ID: 33254033
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
    Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y
    Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
    Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
    Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
    Inokuchi K; Dan K
    J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
    [No Abstract]   [Full Text] [Related]  

  • 17. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
    Martínez-López J; Ayala R; Albizua Q
    Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
    [No Abstract]   [Full Text] [Related]  

  • 18. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods.
    Ozemri Sag S; Yakut T; Gorukmez O; Gorukmez O; Ture M; Karkucak M; Gulten T; Ali R
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):584-8. PubMed ID: 26308792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
    Acar H; Stewart J; Connor MJ
    Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
    So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
    Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.